CHICAGO — Stereotactic body radiation therapy (SBRT) directed at progressive lesions in patients with oligoprogressive metastatic non-small cell lung cancer (NSCLC) was beneficial and significantly ...

Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I ...

Landmark procedure strengthens Africa's capacity for complex cardiac care, reducing reliance on overseas medical travelAbuja, Nigeria,15th December, 2025 -- Only six months since its opening in June ...

Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers. Two-thirds of patients were alive at 2 years with minimal serious toxicity ...

Study is the first to compare 10-year outcomes from surgery and a specific kind of radiation therapy known as SBRT (also called SABR) in non-small cell lung cancer Survival outcomes were similar, but ...

Among consecutive patients receiving SBRT between 2005 and 2019 in our institution, we retrospectively identified those with Tis–T4N0M0 NSCLC. We constructed two NNs for prediction of overall survival ...

Prediction of brain metastases progression and overall survival in patients with metastatic non-small cell lung cancer treated by immune checkpoint inhibitors using a radiomic model. This is an ASCO ...

SBRT and hypofractionated CRT showed similar effectiveness and low severe side effects in stage 1 NSCLC treatment. SBRT delivers higher radiation doses in fewer sessions, while hypofractionated CRT ...

Stereotactic body radiotherapy more than doubled the complete response rate. Stereotactic body radiotherapy (SBRT) was superior to external beam radiotherapy (EBRT) for alleviating pain in cancer ...